DCAL

Dishman Carbogen Amcis Limited

Pharmaceuticals

A contract research and manufacturing services provider specializing in pharmaceuticals and specialty chemicals. Dishman Carbogen delivers comprehensive CRAMS solutions alongside manufacturing marketable molecules including vitamins, specialty chemicals, and disinfectants. With operations spanning Switzerland, the UK, Europe, China, and other countries, the company serves global pharmaceutical and chemical clients. Its integrated approach combines research capabilities with large-scale manufacturing infrastructure to support drug development and production across multiple international markets.

Investors holding Dishman Carbogen Amcis Limited

Mukul Agrawal

Investor

5.50%

Massachusetts Institute Of Technology

Foreign Investor

2.28%

HSBC Mutual Fund

Mutual Fund

1.41%

Latest move